Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products
- 19 June 2015
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 69, 172-175
- https://doi.org/10.1016/j.jcv.2015.06.086
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Structure and inhibition of EV-D68, a virus that causes respiratory illness in childrenScience, 2015
- Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity in Intravenous Immunoglobulin as a Potential Therapeutic Against Emerging Influenza VirusesThe Journal of Infectious Diseases, 2014
- Hyperimmune IV Immunoglobulin TreatmentSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Enterovirus-specific IgG in intravenous immunoglobulin preparationsAnnals of Allergy, Asthma & Immunology, 2011
- Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulinJournal of Medical Virology, 2010
- Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinovirusesJournal of General Virology, 2004
- INTRAVENOUS IMMUNOGLOBULIN PROPHYLAXIS IN AN ECHOVIRUS 6 AND ECHOVIRUS 4 NURSERY OUTBREAKThe Pediatric Infectious Disease Journal, 1997
- Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin ProphylaxisPediatrics, 1997
- Neonatal Enterovirus Infection: Virology, Serology, and Effects of Intravenous Immune GlobulinClinical Infectious Diseases, 1995
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1931